A Flexible Multiwell Format for Immunofluorescence Screening Microscopy of Small-Molecule Inhibitors

被引:2
|
作者
Scholz, Anne-Kathrin [1 ]
Klebl, Bert M. [2 ]
Morkel, Markus [3 ]
Lehrach, Hans [1 ]
Dahl, Andreas [1 ]
Lange, Bodo M. H. [1 ]
机构
[1] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany
[2] GPC Biotech AG, Planegg Martinsried, Germany
[3] Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany
关键词
AURORA KINASE INHIBITOR; CELL-CYCLE; B KINASE; A KINASE; IN-VIVO; P-TEFB; FLAVOPIRIDOL; VX-680; CARCINOMA; APOPTOSIS;
D O I
10.1089/adt.2009.0260
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Large-scale screens in mammalian cells demand for flexible high-throughput screening platforms that allow to analyze cellular traits on a genome-wide level or to identify small-molecule inhibitors (SMIs) from complex compound libraries. In this study we developed and tested high-density cell arrays made out of polydimethylsiloxane (PDMS) that support cell growth directly on standard glass microscope objective slides. We analyzed the effect of 3 reference inhibitors (MLN-8054, VX-680, and flavopiridol) and 4 exploratory, cell permeable small-molecule kinase inhibitors (two benzothiophene-based and two 4-amino-6-arylpyrimidine-based compounds) on different cell lines, using prototype 5 x 5 and 9 x 9 array carpets. We found that high-density PDMS cell arrays support growth of a broad range of cell types, are well suited for compound screens, and are compatible with high-content screening platforms. This novel array format is of particular advantage for compound screening to identify SMIs, when a combination of flexibility with respect to culture volume, well density, and high-resolution imaging is required. In addition, we demonstrated the suitability of this format for reverse transfection and siRNA experiments.
引用
收藏
页码:571 / 580
页数:10
相关论文
共 50 条
  • [41] Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer
    Liu, Ruiwu
    Wettersten, Hiromi I.
    Park, See-Hyoung
    Weiss, Robert H.
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (09) : 991 - 994
  • [42] Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy
    Zhang, Zijuan
    Kwiatkowski, Nicholas
    Zeng, Hong
    Lim, Sang Min
    Gray, Nathanael S.
    Zhang, Wei
    Yang, Priscilla L.
    MOLECULAR BIOSYSTEMS, 2012, 8 (10) : 2523 - 2526
  • [43] Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds
    Gong, Grace Qun
    Wang, Ke
    Dai, Xin-Chuan
    Zhou, Yan
    Basnet, Rajesh
    Chen, Yi
    Yang, De-Hua
    Lee, Woo-Jeong
    Buchanan, Christina Maree
    Flanagan, Jack Urquhart
    Shepherd, Peter Robin
    Chen, Ying
    Wang, Ming-Wei
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (12) : 1902 - 1912
  • [44] Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Chakravarty, Debyani
    Santos, Elmer
    Ryder, Mabel
    Knauf, Jeffrey A.
    Liao, Xiao-Hui
    West, Brian L.
    Bollag, Gideon
    Kolesnick, Richard
    Thin, Tin Htwe
    Rosen, Neal
    Zanzonico, Pat
    Larson, Steven M.
    Refetoff, Samuel
    Ghossein, Ronald
    Fagin, James A.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12) : 4700 - 4711
  • [45] Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma
    Zhou, Xiaoyi
    Jin, Wenke
    Chen, Yanmei
    Zhu, Lingjuan
    Mo, Anchun
    Xie, Qiang
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (04) : 125 - 137
  • [46] Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma
    Grant, Trevor J.
    Bishop, Joshua A.
    Christadore, Lisa M.
    Barot, Girish
    Chin, Hang Gyeong
    Woodson, Sarah
    Kavouris, John
    Siddiq, Ayesha
    Gredler, Rachel
    Shen, Xue-Ning
    Sherman, Jennifer
    Meehan, Tracy
    Fitzgerald, Kevin
    Pradhan, Sriharsa
    Briggs, Laura A.
    Andrews, William H.
    Sarkar, Devanand
    Schaus, Scott E.
    Hansen, Ulla
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (12) : 4503 - 4508
  • [47] Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility
    Kong, Ren
    Bharadwaj, Uddalak
    Eckols, T. Kris
    Kolosov, Mikhail
    Wu, Haoyi
    Cruz-Pavlovich, Francisco J. Santa
    Shaw, Alison
    Ifelayo, Oluwatomilona I.
    Zhao, Hong
    Kasembeli, Moses M.
    Wong, Stephen T. C.
    Tweardy, David J.
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [48] TARGETING MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF): SMALL-MOLECULE INHIBITORS AND THERAPEUTIC STRATEGIES FOR IMMUNE DISORDERS AND CANCER
    Nagarajan, Prithiviraj
    Louis, Leena Rajathy Port
    Rangarajalu, Kumar
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2024, 22 (03): : 284 - 292
  • [49] Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer
    Guo, Chaohua
    Wu, Lintao
    Zheng, Xumei
    Zhao, Lin
    Hou, Xiaojia
    Wang, Zhijun
    Han, Chun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (21) : 2048 - 2074
  • [50] Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1)
    Beekman, Andrew M.
    O'Connell, Maria A.
    Howell, Lesley A.
    CHEMMEDCHEM, 2016, 11 (08) : 840 - 844